Taxotere (Sanofi-Aventis) is a chemotherapy drug used in the treatment of breast cancer, large cell lung cancer, advanced stages of stomach cancer, head and neck cancers, and metastatic prostate cancer. The drug is often used to try to prevent cancer cells from growing and spreading but the chemotherapy drug may have an unintended and unreported side-effect: permanent alopecia, or hair loss.
As a result, many patients who were prescribed Taxotere have suffered permanent hair loss and are filing claims against the manufacturer for failing to warn patients and doctors of this risk.
Taxotere lawsuit attorneys at Cellino & Barnes said if the manufacturer had properly warned patients and doctors of this side effect, a more effective drug that does not result in permanent hair loss may have been prescribed instead.
Several lawsuits have already been filed against Sanofi-Aventis claiming:
- The company concealed evidence and misrepresented the effectiveness of its medication
- The company failed to properly test Taxotere and failed to warn doctors and patients of the strong possibility of permanent hair loss
- Taxotere is unreasonably dangerous
Alopecia is the most common side effect that may be associated with the drug but Taxotere lawsuit lawyers say patients may experience other unintended and devastating side effects.
If you or a loved one has been prescribed Taxotere as part of their chemotherapy regimen, trust a firm that has helped many other victims of dangerous drugs get the best result possible from a claim.
Our attorneys provide free consultations and with our No Fee Promise, we will never charge you any costs unless we win your case.
Contact a Taxotere lawsuit attorney today for a free case evaluation.
Cellino & Barnes (800) 888-8888